A Three Part Study of MGV354 in Ocular Hypertension or Glaucoma

NCT02743780 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

191

Enrollment

INDUSTRY

Sponsor class

Conditions

Ocular Hypertension
Open-Angle Glaucoma

Interventions

DRUG: MGV354 ophthalmic suspension
DRUG: MGV354 placebo

Sponsor

Alcon Research

Collaborators

[object Object]